CompletedNot Applicable

Effect of Vitamin D Supplementation on Metabolic Parameters of Patients With Psoriasis

Chile39 participantsStarted 2014-10

Plain-language summary

The purpose of this study is to determine whether supplementation with oral vitamin D (cholecalciferol) improves metabolic parameters in patients with moderate to severe psoriasis.

Who can participate

Age range18 Years – 80 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Clinical diagnosis of moderate to severe psoriasis. * Being treated with methotrexate with stable doses for al least 1 month. Exclusion Criteria: * Phototherapy within the past 2 months. * History of psoriatic arthritis, rheumatoid arthritis, type 1 diabetes mellitus or inflammatory bowel disease. * Use of vitamin d supplements or fish oil supplements in the past 2 months. * Use of hypolipidemic drugs, hypoglycemic drugs, glucose sensitizers, oral corticosteroids, orlistat, cholestyramine, phenobarbital or phenytoin within the past 2 months. * Pregnancy or lactation.

What they're measuring

Change in Total Cholesterol Levels

Timeframe: Baseline and 6 weeks

Trial details

NCT IDNCT02271971

SponsorPontificia Universidad Catolica de Chile

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2015-04

View on ClinicalTrials.gov More Psoriasis trials